Rosen Law Firm Reminds Insulet Investors of August 31 Lead Plaintiff Deadline

GlobeNewswire··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Rosen Law Firm reminds purchasers of Insulet Corporation securities between February 21, 2025 and May 26, 2026 of the August 31, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Insulet made false and misleading statements about its manufacturing controls and procedures, which created a risk of product safety violations and investor damages when the truth emerged. Investors may be entitled to compensation through a contingency fee arrangement and can join the action by contacting the firm. Rosen Law Firm highlights its track record in securities class actions, including the largest-ever settlement against a Chinese company and over $438 million recovered for investors in 2019.

Impact on assets 1

Biotech & Genomic Medicine▼ · 1 stocks
Insulet Corporation
PODD
▼ NegativeRegulationrelevance

Securities class action alleges false statements about manufacturing controls, posing legal and financial risk.